Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0318 Transporter Info
Gene Name SLC36A1
Transporter Name Proton-coupled amino acid transporter 1
Gene ID
206358
UniProt ID
Q7Z2H8
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Aminocaproic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aminocaproic acid inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  Artemisinin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Artemisinin inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  Cycloserine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cycloserine inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  Gamma-hydroxybutyric acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gamma-hydroxybutyric acid inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  Glycine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glycine inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  L-alanine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 L-alanine inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  L-proline

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 L-proline inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  Tretinoin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tretinoin increases the expression of SLC36A1 [4]

  Acetaminophen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acetaminophen increases the expression of SLC36A1 [5]

  Valproic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valproic Acid increases the expression of SLC36A1 [6]

  Caffeine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Caffeine inhibits the activity of SLC36A1 [7]

Drug in Phase 2/3 Trial

  AM-80

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 AM-80 increases the expression of SLC36A1 [3]

Drug in Phase 3 Trial

  Creatine ALS-08

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Creatine ALS-08 inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  Tramiprosate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tramiprosate inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

Drug in Phase 2 Trial

  Gamma-aminobutyric acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gamma-aminobutyric acid inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  Procysteine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Procysteine inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

Investigative Drug

  Isonipecotic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Isonipecotic acid inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  L-isoleucine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 L-isoleucine inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  L-leucine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 L-leucine inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  L-serine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 L-serine inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  Piperidine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Piperidine inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  Sarcosine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sarcosine inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  Taurine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Taurine inhibits the transportation of L-proline by SLC36A1 [1]

Affected Drug/Substrate

 L-proline Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

  Milchsaure

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Milchsaure inhibits the expression of SLC36A1 [11]

  5-Hydroxy-L-tryptophan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 5-Hydroxy-L-tryptophan inhibits the activity of SLC36A1 [14]

Natural Product

  Thapsigargin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Thapsigargin inhibits the expression of SLC36A1 [9]

  Tobacco Smoke Pollution

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tobacco Smoke Pollution increases the expression of SLC36A1 [13]

Dietary Constituent

  Infant formula

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Infant formula inhibits the transportation of Vigabatrin by SLC36A1 [2]

Affected Drug/Substrate

 Vigabatrin Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-PAT1

Carcinogen

  Sodium bichromate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sodium bichromate inhibits the expression of SLC36A1 [8]

  Benzo(a)pyrene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzo(a)pyrene increases the expression of SLC36A1 [12]

Pesticide/Insecticide

  Dicrotophos

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dicrotophos increases the expression of SLC36A1 [10]

Herbicide

  Atrazine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Atrazine inhibits the expression of SLC36A1 [9]
References
1 Three-dimensional quantitative structure-activity relationship analyses of substrates of the human proton-coupled amino acid transporter 1 (hPAT1). Bioorg Med Chem. 2011 Nov 1;19(21):6409-18.
2 Pharmacokinetic aspects of the anti-epileptic drug substance vigabatrin: focus on transporter interactions. Ther Deliv. 2014 Aug;5(8):927-42.
3 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
4 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423.
5 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
6 Stem Cell Transcriptome Responses and Corresponding Biomarkers That Indicate the Transition from Adaptive Responses to Cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
7 Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3). Biochim Biophys Acta. 2007 Jul;1768(7):1822-9.
8 Identification of human cell responses to hexavalent chromium. Environ Mol Mutagen. 2007 Oct;48(8):650-7.
9 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
10 Molecular mechanisms of discrotophos-induced toxicity in HepG2 cells: The role of CSA in oxidative stress. Food Chem Toxicol. 2017 May;103:253-260.
11 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
12 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297.
13 Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. Arch Toxicol. 2021 May;95(5):1739-1761.
14 The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics. Br J Pharmacol. 2010 Oct;161(3):589-600.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.